Filtros de búsqueda

Lista de obras de Axel Hauschild

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task

artículo científico publicado en 2019

A multimarker prognostic assay for primary cutaneous melanoma

artículo científico publicado en 2009

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients

scientific article published on 03 September 2019

A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.

artículo científico publicado en 2014

Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI)

artículo científico publicado en 2020

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

artículo científico publicado en 2017

Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial

artículo científico publicado en 2020

Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review

artículo científico

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ⬇️

artículo científico publicado en 2021

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) stu

artículo científico

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

artículo científico publicado en 2008

Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group

artículo científico publicado en 2008

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.

artículo científico publicado en 2018

Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers

artículo científico publicado en 2017

Algorithm for the management of metastatic cutaneous melanoma

artículo científico publicado en 2014

An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma

artículo científico publicado en 2008

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

artículo científico publicado en 2015

Analysis of dermatologic events in vemurafenib-treated patients with melanoma

artículo científico publicado en 2013

Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient

artículo científico publicado en 2009

Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study

scientific article published on 11 September 2020

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study

scientific article published on 01 December 2018

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.

artículo científico publicado en 2010

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

artículo científico publicado en 2012

Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha

artículo científico publicado en 2007

Basal cell carcinoma-treatments for the commonest skin cancer

artículo científico publicado en 2014

Bexarotene and systemic disease progression in CTCL?

scientific article published on 01 August 2006

Brief S2k guidelines--Basal cell carcinoma of the skin

artículo científico publicado en 2013

Brief S2k guidelines--Cutaneous squamous cell carcinoma

artículo científico publicado en 2013

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

artículo científico publicado en 2021

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

scientific article published on 14 January 2020

Cerebriform giant melanocytic nevus of the scalp: report of two cases with different surgical approaches

artículo científico publicado en 2002

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

artículo científico publicado en 2016

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

artículo científico publicado en 2011

Co-expression of NGF and PD-L1 on tumor-associated immune cells in the microenvironment of Merkel cell carcinoma.

artículo científico publicado en 2018

Coincident PTCH and BRCA1 germline mutations in a patient with nevoid basal cell carcinoma syndrome and familial breast cancer

artículo científico publicado en 2001

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

artículo científico publicado en 2014

Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma

artículo científico publicado en 2016

Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study

artículo científico publicado en 2008

Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma

scientific article published on 12 September 2011

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

article

Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials.

artículo científico publicado en 2015

Corrigendum to 'Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data' [Eur J Cancer, 119 (September 2019) Pages 30-34]

scientific article published on 07 November 2019

Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]

artículo científico publicado en 2018

Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology

artículo científico publicado en 2008

Cutaneous melanoma: a model to study cancer metastasis

scientific article published on May 2011

Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial).

artículo científico publicado en 2013

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

artículo científico publicado en 2015

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

artículo científico publicado en 2012

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

artículo científico publicado en 2012

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

scientific article published on 10 April 2019

Deep neural networks are superior to dermatologists in melanoma image classification

scientific article published on 08 August 2019

Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial

artículo científico publicado en 2010

Dermatologic adverse events associated with afatinib: an oral ErbB family blocker.

artículo científico publicado en 2013

Descriptive epidemiology of cutaneous melanoma – A treasure for generating hypotheses

artículo científico publicado en 2021

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

artículo científico publicado en 2016

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012

artículo científico publicado en 2012

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

scientific article published on December 2009

Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risks for the fetus?

artículo científico publicado en 2006

Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy

artículo científico publicado en 2005

Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers

artículo científico publicado en 2019

Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis.

artículo científico publicado en 2010

Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma

artículo científico publicado en 2010

Eczematous malignant melanoma: a wolf in sheep's clothing

artículo científico publicado en 2009

Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency

artículo científico publicado en 2015

Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch

artículo científico publicado en 2008

Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutions.

artículo científico publicado en 2014

Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

artículo científico publicado en 2020

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

artículo científico publicado en 2012

Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial

artículo científico publicado en 2010

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

artículo científico publicado en 2017

Electrochemotherapy in symptomatic melanoma skin metastases: intraindividual comparison with conventional surgery

artículo científico publicado en 2010

Erratum to: Progression of cutaneous melanoma: implications fortreatment.

artículo científico publicado en 2012

Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference centers

artículo científico

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

artículo científico publicado en 2023

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019

scientific article published on 09 January 2020

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

artículo científico publicado en 2007

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

artículo científico publicado en 2008

Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.

artículo científico publicado en 2008

Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.

scientific article published on 08 September 2008

Expanded access programmes: patient interests versus clinical trial integrity

artículo científico publicado en 2014

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database

artículo científico publicado en 2011

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma

artículo científico publicado en 2013

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

scientific article published on 02 September 2020

Frontline approach to metastatic BRAF-mutant melanoma diagnosis, molecular evaluation, and treatment choice

artículo científico publicado en 2014

Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".

artículo científico publicado en 2012

Giant Basal Cell Carcinoma of the Breast Mimicking Paget’s Disease: Complete Remission after Photodynamic Therapy ⬇️

artículo científico publicado el 15 de octubre de 2010

Giant naevoid syringocystadenoma papilliferum

scientific article published on 01 January 2005

Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).

artículo científico publicado en 2011

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

artículo científico publicado en 2016

Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study

scholarly article by Max Schmitt et al published 2 February 2021 in Journal of Medical Internet Research

Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma

artículo científico publicado en 2017

Immunotherapy: Combined immunotherapy--a new standard in metastatic melanoma?

artículo científico publicado en 2015

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

scientific article published on 16 August 2019

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials

artículo científico publicado en 2020

Improved overall survival in melanoma with combined dabrafenib and trametinib

artículo científico publicado en 2015

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

artículo científico publicado en 2011

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

artículo científico publicado en 2006

Increased risk of immune checkpoint inhibitor-induced type 1 diabetes mellitus with the new approved 6-week scheme of pembrolizumab in patients with melanoma?

artículo científico publicado en 2020

Individualized therapy of disseminated cancer using malignant melanoma as a model

artículo científico publicado en 2006

Installation of a network for patients with congenital melanocytic nevi in German-speaking countries

artículo científico publicado en 2007

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

publication published on 02 July 2021

Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?

artículo científico

Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy

artículo científico publicado en 2008

Interdisziplinäres Experten-Treffen „Quo vadis beim kutanen Plattenepithelkarzinom“

artículo científico publicado en 2020

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial

artículo científico publicado en 2015

Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma

artículo científico publicado en 2003

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives

artículo científico publicado en 2020

Ipilimumab in patients with cancer and the management of dermatologic adverse events

artículo científico

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

artículo científico publicado en 2011

Kissing melanoma or kissing nevus of the penis?

artículo científico publicado en 2007

Linear intraoral lesions in the sebaceous nevus syndrome

scientific article published on 01 February 2005

Long-term efficacy of subcutaneous sweat gland suction curettage for axillary hyperhidrosis: a prospective gravimetrically controlled study.

artículo científico publicado en 2008

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

scientific article published on 01 January 2020

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

artículo científico publicado en 2017

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

artículo científico publicado en 2008

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

article

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article published on 13 June 2018

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

artículo científico publicado en 2013

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

artículo científico publicado en 2013

Malignant melanoma and HIV infection -- aggressive course despite immune reconstitution

scientific article published on 01 January 2005

Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician

artículo científico publicado en 2010

Management of immune-related adverse events and kinetics of response with ipilimumab

artículo científico publicado en 2012

Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma

artículo científico publicado en 2012

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Melanocytic nevi

artículo científico publicado en 2011

Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literature

artículo científico publicado en 2008

Melanoma

2015 article in Nature Reviews Disease Primers

Melanoma

artículo científico publicado en 2018

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries

artículo científico publicado en 2015

Melanoma in 2013: Melanoma--the run of success continues

artículo científico

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis

artículo científico publicado en 2020

Melanomas of unknown primary frequently harbor TERT-promoter mutations

artículo científico publicado en 2014

Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease

artículo científico publicado en 2014

Metastatic melanoma of the tongue arising from oral melanosis

artículo científico publicado en 2008

Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results

artículo científico publicado en 2008

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations

artículo científico publicado en 2015

Molecularly targeted therapy for melanoma: current reality and future options

artículo científico publicado en 2006

Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors

artículo científico

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

artículo científico publicado en 2008

Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma

artículo científico publicado en 2003

Multiple skin metastases of malignant melanoma with unusual clinical and histopathologic features in an immunosuppressed patient

artículo científico publicado en 2008

Multiple squamous cell carcinomas in junctional epidermolysis bullosa: a surgical challenge

artículo científico publicado en 2008

Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up

artículo científico publicado en 2013

Neurocutaneous melanosis: a fatal disease in early childhood

scientific article published on 06 April 2009

New promises in the adjuvant, and palliative treatment of melanoma.

artículo científico publicado en 2007

Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays

artículo científico publicado en 2015

Obituary for Prof. Dr. med. Christiane Voit (Berlin)

artículo científico publicado en 2015

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.

artículo científico publicado en 2015

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

artículo científico publicado en 2017

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials.

artículo científico publicado en 2014

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

scientific article published on 04 June 2018

Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line.

artículo científico publicado en 2005

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

scientific article published on 27 March 2019

Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma

artículo científico publicado en 2010

Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts

artículo científico publicado en 2008

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

artículo científico publicado en 2020

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

artículo científico publicado en 2015

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

scientific article published on 19 January 2010

Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma

artículo científico publicado en 2013

Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption

artículo científico publicado en 2008

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.

artículo científico

Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion

artículo científico publicado en 2008

Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data

scientific article published on 08 August 2019

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

artículo científico publicado en 2016

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

artículo científico publicado en 2020

Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patients

artículo científico publicado en 2020

Prognostische Genexpressionstests beim Melanom auf dem Weg in die Routine

artículo científico publicado en 2020

Progression of cutaneous melanoma: implications for treatment

artículo científico publicado en 2012

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

artículo científico publicado en 2016

Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial

artículo científico publicado en 2011

Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse

artículo científico publicado en 2009

Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.

artículo científico publicado en 2009

Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis

scientific article published on 01 August 2003

Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma

artículo científico publicado en 2009

Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG)

artículo científico publicado en 2003

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.

artículo científico publicado en 2017

Recent aspects of medical care of malignant melanoma

artículo científico publicado en 2008

Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study

artículo científico publicado en 2018

Regression of a basal cell carcinoma infiltrating the brain after vismodegib therapy

artículo científico publicado en 2014

Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.

artículo científico publicado en 2017

Reply to E. Hindié and K.R. Hess

artículo científico publicado en 2019

Reply to K.S. Wilson et al

scientific article published on 01 August 2013

Reply to N. Rompoti et al.

artículo científico publicado en 2013

Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'

scientific article published on 22 September 2020

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

artículo científico publicado en 2009

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis

scientific article published on 28 December 2018

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up

scientific article published on 01 February 2019

S2k-Leitlinie Basalzellkarzinom der Haut - Teil 1: Epidemiologie, Genetik und Diagnostik

artículo científico publicado en 2019

S2k-Leitlinie Basalzellkarzinom der Haut - Teil 2: Therapie, Prävention und Nachsorge

scientific article published on 01 February 2019

S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version

artículo científico publicado en 2013

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

artículo científico publicado en 2014

Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trial

artículo científico publicado en 2003

Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy.

artículo científico publicado en 2013

Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients

artículo científico publicado en 2010

Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.

artículo científico publicado en 2016

Short German guidelines: Merkel cell carcinoma

artículo científico publicado en 2008

Short German guidelines: basal cell carcinoma.

artículo científico publicado en 2008

Short German guidelines: malignant melanoma

artículo científico publicado en 2008

Short German guidelines: squamous cell carcinoma

scientific article published on 01 May 2008

Side effects and toxicities of targeted therapies in stage IV melanoma

artículo científico

Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.

artículo científico publicado en 2002

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

artículo científico publicado en 2014

Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019

scientific article published on 13 March 2020

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

artículo científico

Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.

artículo científico publicado en 2017

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks

artículo científico publicado en 2019

Systematic review of medical treatment in melanoma: current status and future prospects.

artículo científico publicado en 2011

Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?

artículo científico publicado en 2008

The Impact of Multispectral Digital Skin Lesion Analysis on German Dermatologist Decisions to Biopsy Atypical Pigmented Lesions with Clinical Characteristics of Melanoma

artículo científico publicado en 2015

The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans

artículo científico publicado en 2010

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians.

artículo científico publicado en 2018

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

artículo científico publicado en 2013

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

artículo científico publicado en 2017

To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions

artículo científico publicado en 2014

Treatment algorithms in stage IV melanoma

artículo científico

Treatment and side effect management of CTLA‐4 antibody therapy in metastatic melanoma ⬇️

artículo científico publicado el 17 de noviembre de 2010

Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases

artículo científico publicado en 2005

Tropomyosin Receptor Kinase A Expression on Merkel Cell Carcinoma Cells

artículo científico publicado en 2017

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

artículo científico publicado en 2005

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

artículo científico publicado en 2017

Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management

artículo científico publicado en 2010

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

artículo científico publicado en 2013

Varying Mutational Alterations in Multiple Primary Melanomas

artículo científico publicado en 2015

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

artículo científico publicado en 2014

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial

artículo científico publicado en 2015

Who benefits most from adjuvant interferon treatment for melanoma?

artículo científico publicado en 2015

Willingness to pay for a cure of low-risk melanoma patients in Germany.

artículo científico publicado en 2018

[Actinic keratoses].

artículo científico publicado en 2012

[Brief guideline--cutaneous neuroendocrine carcinoma (Merkel cell carcinoma]

scientific article published on 01 June 2006

[Brief guidelines: malignant melanoma of the skin]

artículo científico publicado en 2006

[Clinical studies with sorafenib (Nexavar) in metastatic melanoma]

scientific article published on 01 April 2007

[Foreword]

artículo científico publicado en 2012

[Foreword].

artículo científico publicado en 2013

[Forward]

artículo científico publicado en 2011

[Immunonkologie beim malignen Melanom: Von der Monotherapie zur Kombinationstherapie - aktuelle Studiendaten und Fragestellungen]

artículo científico publicado en 2016

[Melanocytic nevi]

artículo científico publicado en 2006

[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy].

artículo científico publicado en 2015

[Sentinel lymph node biopsy]

scientific article published on 01 September 2005

[Vorwort]

artículo científico publicado en 2016

[Working Group on Dermatological Oncology]

artículo científico publicado en 2014

[Working group of the Dermatologic Oncology]

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda